• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验中无症状动脉粥样硬化的检测与监测。

Detection and monitoring of asymptomatic atherosclerosis in clinical trials.

作者信息

Bond M G, Wilmoth S K, Enevold G L, Strickland H L

机构信息

Department of Anatomy, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27103.

出版信息

Am J Med. 1989 Apr 17;86(4A):33-6. doi: 10.1016/0002-9343(89)90187-3.

DOI:10.1016/0002-9343(89)90187-3
PMID:2523652
Abstract

Methods are currently available to noninvasively detect and evaluate asymptomatic atherosclerosis in the carotid artery, and provide a unique opportunity to monitor the effect of medical intervention during the early stages of atherosclerotic progression. When using high-resolution B-mode ultrasound to monitor lesion change over time, it is the reproducibility of measurements at the arterial wall and lumen that defines the confidence of establishing rates of disease progression. Previous studies have demonstrated that, in a research environment using standardized protocols for scanning and interpretation, the absolute difference between blinded replicate measurements of arterial wall thicknesses at sites of lesion is less than 0.2 mm. The Multicenter Isradipine Diuretic Atherosclerosis Study will use high-resolution B-mode ultrasound to determine the effect of isradipine and hydrochlorothiazide on the rate of progression of carotid artery atherosclerosis in hypertensive subjects. Methods for scanning and interpretation of arterial wall thickenings are presented.

摘要

目前已有方法可用于非侵入性检测和评估颈动脉无症状性动脉粥样硬化,并为监测动脉粥样硬化进展早期阶段的医学干预效果提供了独特的机会。当使用高分辨率B型超声监测病变随时间的变化时,动脉壁和管腔测量的可重复性决定了确定疾病进展速率的可信度。先前的研究表明,在采用标准化扫描和解读方案的研究环境中,病变部位动脉壁厚度的双盲重复测量之间的绝对差异小于0.2毫米。多中心伊拉地平利尿剂动脉粥样硬化研究将使用高分辨率B型超声来确定伊拉地平和氢氯噻嗪对高血压患者颈动脉粥样硬化进展速率的影响。本文介绍了动脉壁增厚的扫描和解读方法。

相似文献

1
Detection and monitoring of asymptomatic atherosclerosis in clinical trials.临床试验中无症状动脉粥样硬化的检测与监测。
Am J Med. 1989 Apr 17;86(4A):33-6. doi: 10.1016/0002-9343(89)90187-3.
2
Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group.多中心伊拉地平利尿剂动脉粥样硬化研究(MIDAS)。设计特点。MIDAS研究小组。
Am J Med. 1989 Apr 17;86(4A):37-9. doi: 10.1016/0002-9343(89)90188-5.
3
Interventional clinical trials using noninvasive ultrasound end points: the Multicenter Isradipine/Diuretic Atherosclerosis Study. The MIDAS Research Group.
J Cardiovasc Pharmacol. 1990;15 Suppl 1:S30-3.
4
MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline data.MIDAS研究,即多中心伊拉地平/利尿剂动脉粥样硬化研究。设计特点与基线数据。
Am J Hypertens. 1991 Feb;4(2 Pt 2):114S-117S. doi: 10.1093/ajh/4.2.114s.
5
Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research Group.
J Cardiovasc Pharmacol. 1990;15 Suppl 1:S23-9.
6
The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group.多中心伊拉地平/利尿剂动脉粥样硬化研究:伊拉地平对高血压患者抗动脉粥样硬化特性的研究。MIDAS研究组
J Cardiovasc Pharmacol. 1991;18 Suppl 3:S15-9.
7
A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
Drugs. 1990;40 Suppl 2:38-43. doi: 10.2165/00003495-199000402-00011.
8
MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group.
J Cardiovasc Pharmacol. 1992;19 Suppl 3:S16-20.
9
Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.多中心伊拉地平利尿剂动脉粥样硬化研究(MIDAS)的最终结果。一项随机对照试验。
JAMA. 1996 Sep 11;276(10):785-91.
10
The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study.钙拮抗剂对人体的抗动脉粥样硬化作用——MIDAS研究实际显示了什么?多中心伊拉地平利尿剂动脉粥样硬化研究。
Blood Press. 1995 May;4(3):133-6. doi: 10.3109/08037059509077584.

引用本文的文献

1
Coronary Flow Velocity Reserve by Echocardiography: Beyond Atherosclerotic Disease.超声心动图评估的冠状动脉血流储备:超越动脉粥样硬化疾病
Diagnostics (Basel). 2023 Jan 5;13(2):193. doi: 10.3390/diagnostics13020193.
2
Effect of comprehensive cardiovascular disease risk management on longitudinal changes in carotid artery intima-media thickness in a community-based prevention clinic.社区预防诊所中综合心血管疾病风险管理对颈动脉内膜中层厚度纵向变化的影响。
Arch Med Sci. 2016 Aug 1;12(4):728-35. doi: 10.5114/aoms.2016.60955. Epub 2016 Jul 1.
3
Helicobacter pylori infection is identified as a cardiovascular risk factor in Central Africans.
幽门螺杆菌感染被确定为中非人的心血管危险因素。
Vasc Health Risk Manag. 2012;6:455-61. doi: 10.2147/VHRM.S28680. Epub 2012 Aug 15.
4
Relationship between tooth loss and carotid intima-media thickness in Korean adults.韩国成年人牙齿缺失与颈动脉内膜中层厚度的关系。
J Adv Prosthodont. 2010 Dec;2(4):122-7. doi: 10.4047/jap.2010.2.4.122. Epub 2010 Dec 31.
5
The antiatherogenic effects of antihypertensive treatment: trials completed and ongoing.抗高血压治疗的抗动脉粥样硬化作用:已完成和正在进行的试验
Curr Hypertens Rep. 2001 Aug;3(4):350-9. doi: 10.1007/s11906-001-0098-3.
6
Flow resistance and its components in hypertensive men treated with the calcium antagonist isradipine.接受钙拮抗剂伊拉地平治疗的高血压男性的血流阻力及其组成部分。
Eur J Clin Pharmacol. 1992;43(5):463-8. doi: 10.1007/BF02285086.